4AB:ETR
AbbVie Common Stock
236,80 €
arrow_upward
+1,15%(+2,70) 1D
6 қаз., 17:35:38 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
237,30 €
High
238,00 €
Low
233,10 €
Mkt. cap
466,06 млрд
Avg. vol.
664,00
Volume
870,00
52-wk high
238,00 €
52-wk low
162,85 €
No. of employees
57 мың
Open
237,30 €
High
238,00 €
Low
233,10 €
Mkt. cap
466,06 млрд
Avg. vol.
664,00
Volume
870,00
52-wk high
238,00 €
52-wk low
162,85 €
No. of employees
57 мың
News stories
From web sources and news partners
GuruFocus
·
4 сағат бұрын
AbbVie Stocks Edge Higher as Lymphoma Trial Cuts Progression Risk 51%
The Motley Fool
·
5 сағат бұрын
HSBC Thinks AbbVie Can Climb to $315. Here's the Bull Case in Plain English.
The Globe and Mail
·
6 сағат бұрын
AbbVie's Epcoritamab Combo Shows PFS Benefit in Frontline DLBCL
AD HOC NEWS
·
7 сағат бұрын
AbbVie stock cuts its Q3 EPS guidance to USD 3.730-3.770
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 мың
Founded2012 ж. 10 сәу.
HeadquartersNorth Chicago, Иллинойс, Америка Құрама Штаттары
Sector-
Websiteabbvie.com